Controversy over the classification of medication-overuse headache

Current Pain and Headache Reports

Volumn 16, Issue 1, 2012, Pages 80-85

  Vincent, Maurice B ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Analgesics; Chronic daily headache; Chronic headache; Chronic migraine; Chronification; Classification; International Classification of Headache Disorders; Medication overuse headache; Triptans

Indexed keywords

ANALGESIC AGENT; ERGOTAMINE DERIVATIVE; NARCOTIC ANALGESIC AGENT; TRIPTAN DERIVATIVE;

CHRONIC DAILY HEADACHE; CHRONIC TENSION HEADACHE; DISEASE CLASSIFICATION; DRUG INDUCED HEADACHE; FAMILY HISTORY; GENETIC POLYMORPHISM; HUMAN; MOOD DISORDER; NEUROIMAGING; PATHOPHYSIOLOGY; REVIEW; SUBSTANCE ABUSE; TRANSFORMED MIGRAINE; WITHDRAWAL SYNDROME;

BEHAVIOR, ADDICTIVE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FAMILY HEALTH; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MEDICAL HISTORY TAKING; QUESTIONNAIRES;

EID: 84857637281     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-011-0229-8     Document Type: Review

References (32)

1. Osler W, Bean RB. Sir William Osler: aphorisms from his bedside teachings and writings. 2nd ed. Springfield: Charles C. Thomas; 1961.
2. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia. 2004;24 Suppl 1.
3. P Jonsson T Hedenrud M Linde 2011 Epidemiology of medication overuse headache in the general Swedish population Cephalalgia 31 9 1015 1022 21628444 10.1177/0333102411410082
4. K Aaseth RB Grande KJ Kvaerner P Gulbrandsen C Lundqvist MB Russell 2008 Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache Cephalalgia 28 7 705 713 18498398 1:STN:280:DC%2BD1cznvVaruw%3D%3D 10.1111/j.1468-2982.2008. 01577.x (Pubitemid 351799748)
5. R Colas P Munoz R Temprano C Gomez J Pascual 2004 Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life Neurology, EUA 62 8 1338 1342 1:STN:280:DC%2BD2c3htlyjtA%3D%3D (Pubitemid 38526046)
6. Z Katsarava A Dzagnidze M Kukava E Mirvelashvili M Djibuti M Janelidze, et al. 2009 Primary headache disorders in the Republic of Georgia: prevalence and risk factors Neurology, EUA 73 21 1796 1803 1:STN:280:DC%2BD1MjptFWntg%3D%3D 10.1212/WNL.0b013e3181c34abb
7. A Straube V Pfaffenrath KH Ladwig C Meisinger W Hoffmann K Fendrich, et al. 2010 Prevalence of chronic migraine and medication overuse headache in Germany-the German DMKG headache study Cephalalgia 30 2 207 213 19489879 1:STN:280:DC%2BC3cfmt12gsQ%3D%3D
8. ME Bigal AM Rapoport FD Sheftell SJ Tepper RB Lipton 2004 Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes Cephalalgia 24 6 483 490 15154858 1:STN:280:DC%2BD2czhs12isw%3D%3D 10.1111/j.1468-2982.2004.00691.x (Pubitemid 38748030)
9. Z Katsarava S Schneeweiss T Kurth U Kroener G Fritsche A Eikermann, et al. 2004 Incidence and predictors for chronicity of headache in patients with episodic migraine Neurology, EUA 62 5 788 790 1:STN:280:DC%2BD2c7hslektw%3D%3D (Pubitemid 38298959)
10. S Ashina A Lyngberg R Jensen 2010 Headache characteristics and chronification of migraine and tension-type headache: a population-based study Cephalalgia 30 8 943 952 20656705 This comprehensive cross-sectional and longitudinal population study involving 740 individuals (with 673 eligible for follow-up) addresses risk factors for migraine and tension-type headache chronification
11. AC Lyngberg BK Rasmussen T Jorgensen R Jensen 2005 Prognosis of migraine and tension-type headache: a population-based follow-up study Neurology, EUA 65 4 580 585 10.1212/01.wnl.0000172918.74999.8a (Pubitemid 41170718)
12. AI Scher LA Midgette RB Lipton 2008 Risk factors for headache chronification Headache 48 1 16 25 18184281 10.1111/j.1526-4610.2007.00970.x
13. A Bahra M Walsh S Menon PJ Goadsby 2003 Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43 3 179 190 12603636 10.1046/j.1526-4610.2003.03041.x (Pubitemid 36348764)
14. SM Wilkinson WJ Becker JA Heine 2001 Opiate use to control bowel motility may induce chronic daily headache in patients with migraine Headache 41 3 303 309 11264692 1:STN:280:DC%2BD3M7ms1ehtQ%3D%3D 10.1046/j.1526-4610.2001. 111006303.x (Pubitemid 32242617)
15. F Radat C Creach JD Swendsen M Lafittau S Irachabal V Dousset, et al. 2005 Psychiatric comorbidity in the evolution from migraine to medication overuse headache Cephalalgia 25 7 519 522 15955038 1:STN:280: DC%2BD2MzgvVWnsw%3D%3D 10.1111/j.1468-2982.2005.00910.x (Pubitemid 40896016)
16. S Cevoli E Sancisi D Grimaldi G Pierangeli S Zanigni M Nicodemo, et al. 2009 Family history for chronic headache and drug overuse as a risk factor for headache chronification Headache 49 3 412 418 19267785 10.1111/j.1526-4610.2008. 01257.x
17. C Di Lorenzo G Di Lorenzo G Sances N Ghiotto E Guaschino GS Grieco, et al. 2009 Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism J Headache Pain 10 5 349 355 19517061 10.1007/s10194-009-0136-0
18. S Cevoli M Mochi C Scapoli N Marzocchi G Pierangeli LA Pini, et al. 2006 A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse Eur J Neurol 13 9 1009 1013 16930369 1:STN:280:DC%2BD28rgs1OhtA%3D%3D 10.1111/j.1468-1331.2006.01415.x (Pubitemid 44284910)
19. J Gelernter HR Kranzler SL Satel PA Rao 1994 Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia Neuropsychopharmacology 11 3 195 200 7865100 1:CAS:528:DyaK2MXis1Srsbk%3D 10.1038/sj.npp.1380106 (Pubitemid 24351287)
20. TP Laine A Ahonen P Rasanen T Pohjalainen J Tiihonen J Hietala 2001 The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics Alcohol Alcohol 36 3 262 265 11373265 1:CAS:528:DC%2BD3MXltV2mtbk%3D (Pubitemid 32519863)
21. I Ayzenberg M Obermann P Nyhuis M Gastpar V Limmroth HC Diener, et al. 2006 Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures Cephalalgia 26 9 1106 1114 16919061 1:STN:280:DC%2BD28vpsVaisQ%3D%3D 10.1111/j.1468-2982.2006.01183.x (Pubitemid 44199402)
22. T Schmidt-Wilcke E Leinisch A Straube N Kampfe B Draganski HC Diener, et al. 2005 Gray matter decrease in patients with chronic tension type headache Neurology, EUA 65 9 1483 1486 1:STN:280:DC%2BD2Mrps12ktA%3D%3D 10.1212/01.wnl.0000183067.94400.80 (Pubitemid 41552788)
23. A Fumal S Laureys L Di Clemente M Boly V Bohotin M Vandenheede, et al. 2006 Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine Brain 129 Pt 2 543 550 16330505 (Pubitemid 43164376)
24. ED London M Ernst S Grant K Bonson A Weinstein 2000 Orbitofrontal cortex and human drug abuse: functional imaging Cereb Cortex 10 3 334 342 10731228 1:STN:280:DC%2BD3c7ps1ajsA%3D%3D 10.1093/cercor/10.3.334 (Pubitemid 30159300)
25. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988;8 Suppl 7:1-96.
26. SD Silberstein J Olesen MG Bousser HC Diener D Dodick M First, et al. 2005 The International Classification of Headache Disorders, 2nd Edition (ICHD-II)-revision of criteria for 8.2 Medication-overuse headache Cephalalgia 25 6 460 465 15910572 1:STN:280:DC%2BD2M3mvVGiug%3D%3D 10.1111/j.1468-2982.2005. 00878.x (Pubitemid 40769867)
27. C Sun-Edelstein ME Bigal AM Rapoport 2009 Chronic migraine and medication overuse headache: clarifying the current International Headache Society classification criteria Cephalalgia 29 4 445 452 19291245 1:STN:280: DC%2BD1M3htlWqug%3D%3D 10.1111/j.1468-2982.2008.01753.x This article analyzes controversies focusing chronic migraine (CM) and medication-overuse headache (MOH) to address confusion among different terms referring to frequent headaches. The authors favor the incorporation of the ICHD-IIR proposal for the diagnosis of CM and MOH because it addresses problems related to the previous classification version. The possibility of identifying MOH patients without necessarily proving that the headache was produced by the offending drug after withdrawal and new possibilities of classifications according to the abuse of combined medications are discussed
28. RK Cady RB Lipton C Hall WF Stewart S O'Quinn D Gutterman 2000 Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study Headache 40 10 792 797 11135022 1:STN:280:DC%2BD3M7jvFaltw%3D%3D 10.1046/j.1526-4610.2000.00144.x (Pubitemid 32053239)
29. J Olesen MG Bousser HC Diener D Dodick M First PJ Goadsby, et al. 2006 New appendix criteria open for a broader concept of chronic migraine Cephalalgia 26 6 742 746 16686915 1:STN:280:DC%2BD283mt1Gruw%3D%3D 10.1111/j.1468-2982. 2006.01172.x
30. A Ferrari C Coccia E Sternieri 2008 Past, present, and future prospects of medication-overuse headache classification Headache 48 7 1096 1102 18687082 10.1111/j.1526-4610.2008.00919.x The authors made an objective review analyzing the past and present aspects concerning the classification of headaches related to medication overuse. They suggest the categories probable and definite medication-overuse headache (MOH) should remain, and propose subforms of MOH according to the class of abused drugs (Pubitemid 351952106)
31. JR Saper AE Lake 3rd 2006 Medication overuse headache: type I and type II Cephalalgia 26 10 1262 16961800 1:STN:280:DC%2BD28rjs12iug%3D%3D 10.1111/j.1468-2982.2006.01198.x (Pubitemid 44359354)
32. JR Saper RL Hamel AE Lake 3rd 2005 Medication overuse headache (MOH) is a biobehavioural disorder Cephalalgia 25 7 545 546 15955043 1:STN:280: DC%2BD2MzksFGrtw%3D%3D 10.1111/j.1468-2982.2005.00879.x (Pubitemid 40896021)